Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-04-01
2023-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bone Density and Marginal Bone Height Changes Around Dental Implants
NCT06151314
Evaluation of Marginal Bone Loss After Immediate Implant Placement in Esthetic Zone Without Xenograft.
NCT03397316
Clinical and Radiographic Evaluation of Three Different Modalities for Management of Distal Extension Atrophied Mandibular Ridge: A One Year Prospective Study
NCT05978115
Implants Placed With Crestal Sinus Approach Versus Osseodensification in Atrophic Posterior Maxilla
NCT06207578
Different Implant Positions for Implant Retained Mandibular Overdenture
NCT06055842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group I patients will receive mandibular implant supported removable overdenture, while Group II will receive mandibular implant supported fixed overdenture.
All patients will be given the usual home care instructions about wearing and caring of dentures and opposing arch. Regarding dentures, removal of them at night and cleaning with denture brush and mild soap will be required. Measurements of Bone height and Bone density will be obtained by using Cone Beam Computed Tomography (CBCT).
Measurements will be obtained at denture insertion, after 1 month and after 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1
patients received mandibular implant supported removable overdenture
assessment of change in bone height by cone beam computed tomography
bone height was measured at 1 ,30 ,90 days after denture insertion
group 2
patients received mandibular implant supported fixed overdenture
assessment of change in bone height by cone beam computed tomography
bone height was measured at 1 ,30 ,90 days after denture insertion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
assessment of change in bone height by cone beam computed tomography
bone height was measured at 1 ,30 ,90 days after denture insertion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Highly cooperative and motivated patients.
* Patients Systemically free from any immunosuppressive diseases.
Exclusion Criteria
* Mandibular arch with thin knife edge, flat or flabby ridge, recent extractions and foreign bodies.
* Patients with temporo-mandibular joint disorders and bad oral habits.
40 Years
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Menatallah Mohamed Elhotieby
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Menatallah Mohamed Elhotieby
researcher fixed and removable prosthodontics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Menatallah Elhotieby, Researcher
Role: PRINCIPAL_INVESTIGATOR
National Research Centre, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Research Centre
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1431022023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.